Yuli Wang

863 total citations
33 papers, 679 citations indexed

About

Yuli Wang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yuli Wang has authored 33 papers receiving a total of 679 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yuli Wang's work include RNA modifications and cancer (6 papers), MicroRNA in disease regulation (5 papers) and Cancer-related molecular mechanisms research (5 papers). Yuli Wang is often cited by papers focused on RNA modifications and cancer (6 papers), MicroRNA in disease regulation (5 papers) and Cancer-related molecular mechanisms research (5 papers). Yuli Wang collaborates with scholars based in China, United States and Slovenia. Yuli Wang's co-authors include Christine Jacobs, Junhui Bian, Yi Sun, Chunsheng Gao, Baoguo Zhou, Haiquan Qiao, Lingling Zu, Yang Li, Min Wang and Jian Huang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and Journal of Cleaner Production.

In The Last Decade

Yuli Wang

30 papers receiving 668 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuli Wang China 16 410 267 128 73 55 33 679
Biagio Pucci Italy 19 614 1.5× 189 0.7× 141 1.1× 127 1.7× 53 1.0× 33 918
Hui Li Ang Singapore 12 500 1.2× 245 0.9× 142 1.1× 78 1.1× 70 1.3× 13 862
Dahai Jiang China 14 685 1.7× 394 1.5× 149 1.2× 58 0.8× 53 1.0× 37 977
Chunyu Li China 19 533 1.3× 265 1.0× 96 0.8× 68 0.9× 95 1.7× 37 811
Vadim S. Pokrovsky Russia 21 646 1.6× 171 0.6× 128 1.0× 63 0.9× 85 1.5× 111 1.2k
Bing Ji China 16 450 1.1× 251 0.9× 110 0.9× 95 1.3× 95 1.7× 29 802
Zhibo Hou China 16 591 1.4× 415 1.6× 78 0.6× 70 1.0× 37 0.7× 28 864
Esteban A. Orellana United States 13 736 1.8× 388 1.5× 118 0.9× 41 0.6× 41 0.7× 16 1.1k
Septelia Inawati Wanandi Indonesia 14 390 1.0× 133 0.5× 136 1.1× 32 0.4× 35 0.6× 116 778
Canfeza Sezgin Türkiye 14 325 0.8× 108 0.4× 210 1.6× 81 1.1× 38 0.7× 45 695

Countries citing papers authored by Yuli Wang

Since Specialization
Citations

This map shows the geographic impact of Yuli Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuli Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuli Wang more than expected).

Fields of papers citing papers by Yuli Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuli Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuli Wang. The network helps show where Yuli Wang may publish in the future.

Co-authorship network of co-authors of Yuli Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yuli Wang. A scholar is included among the top collaborators of Yuli Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuli Wang. Yuli Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Wanyi, Yufei Guo, Mengxue Gao, et al.. (2025). Noncanonical amino acid-aided synthesis of anti-PD-L1 bispecific nanobody for colon cancer immunotherapy. Communications Biology. 8(1). 1844–1844.
2.
Wu, Jing, Alireza Mohseni, Mihir Khunte, et al.. (2025). Federated Learning for Renal Tumor Segmentation and Classification on Multi‐Center MRI Dataset. Journal of Magnetic Resonance Imaging. 62(3). 814–824.
3.
Qin, Ran, Jun Cao, Jianfeng Li, et al.. (2025). Targeting iron overload and macrophage polarization to treat diabetic periodontitis: Mechanisms and therapeutic strategies. Life Sciences. 377. 123805–123805. 1 indexed citations
5.
Shang, Ye, Yameng Zhu, Yang Liu, et al.. (2024). A UPLC-MS/MS coupled with GC-MS method for quantification of twenty-one chemical ingredients from Suxiao Jiuxin pill in multiple tissue of rat and its application to tissue distribution study. Journal of Pharmaceutical and Biomedical Analysis. 252. 116461–116461. 1 indexed citations
6.
Wang, Jiewen, Guangbo Kang, Huiying Lu, et al.. (2024). Novel bispecific nanobody mitigates experimental intestinal inflammation in mice by targeting TNF‐α and IL‐23p19 bioactivities. Clinical and Translational Medicine. 14(3). e1636–e1636. 7 indexed citations
7.
Wu, Haoran, et al.. (2024). Clean production of xylose via formic acid hydrolysis: Heterogeneous kinetics and economic evaluation. Journal of Cleaner Production. 486. 144437–144437.
8.
Zhang, Ning, Jian Huang, Mei Xu, & Yuli Wang. (2022). LncRNA T-UCR Uc.339/miR-339/SLC7A11 Axis Regulates the Metastasis of Ferroptosis-Induced Lung Adenocarcinoma. Journal of Cancer. 13(6). 1945–1957. 32 indexed citations
9.
10.
Wang, Yuli, Ye Yuan, Xiaoxiao Luo, Guangyuan Hu, & Ping Gong. (2019). Genetic Variants in EGFR/PLCE1 Pathway Are Associated with Prognosis of Esophageal Squamous Cell Carcinoma after Radical Resection. Current Medical Science. 39(3). 385–390. 2 indexed citations
12.
Chu, Xiaoyang, Wei Huang, Yuli Wang, et al.. (2019). <p>Improving antitumor outcomes for palliative intratumoral injection therapy through lecithin&ndash;chitosan nanoparticles loading paclitaxel&ndash;cholesterol complex</p>. International Journal of Nanomedicine. Volume 14. 689–705. 48 indexed citations
13.
Chen, Lu, Xiaoyang Chu, Chun‐Hong Gao, et al.. (2019). Polymer Distribution and Mechanism Conversion in Multiple Media of Phase-Separated Controlled-Release Film-Coating. Pharmaceutics. 11(2). 80–80. 14 indexed citations
14.
Li, Yong, Ping Gong, Wei Huang, et al.. (2018). miR-34a Regulates Multidrug Resistance via Positively Modulating OAZ2 Signaling in Colon Cancer Cells. Journal of Immunology Research. 2018. 1–13. 29 indexed citations
15.
Wang, Yuli, Wei Yuan, Xiaoping Ma, Xinyu Ma, & Ping Gong. (2018). Association between advanced NSCLC T790 M EGFR-TKI secondary resistance and prognosis. Medicine. 97(28). e11346–e11346. 11 indexed citations
16.
Yang, Meiyan, et al.. (2014). Preparation and evaluation of orally disintegrating tablets of taste masked phencynonate HCl using ion-exchange resin. Drug Development and Industrial Pharmacy. 41(6). 934–941. 21 indexed citations
17.
Wang, Yuli, Jiahui Yang, Yong Qian, et al.. (2014). Novel ethylcellulose-coated pellets for controlled release of metoprolol succinate without lag phase: characterization, optimization andin vivoevaluation. Drug Development and Industrial Pharmacy. 41(7). 1120–1129. 7 indexed citations
18.
Feng, Yu-Mei, Baocun Sun, Xiaoqing Li, et al.. (2006). Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients. Breast Cancer Research and Treatment. 103(3). 319–329. 100 indexed citations
19.
Sun, Yi, Junhui Bian, Yuli Wang, & Christine Jacobs. (1997). Activation of p53 transcriptional activity by 1,10-phenanthroline, a metal chelator and redox sensitive compound. Oncogene. 14(4). 385–393. 66 indexed citations
20.
Wang, Yuli. (1991). Dynamics of the cytoskeleton in live cells. Current Opinion in Cell Biology. 3(1). 27–32. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026